Both in Pharmaceuticals
Ardelyx vs Verastem
Over the past year ARDX returned −38.8% and VSTM returned −9.0%; their daily moves had a correlation of 0.22.
ARDX −38.8% VSTM −9.0%Growth of $1, one year, split-adjusted
| Metric | ARDX | VSTM |
|---|---|---|
| Price | $3.09 | $8.65 |
| Market cap | $797.8M | $783.4M |
| Today | −5.50% | −6.28% |
| 1 month | −8.6% | +14.6% |
| 6 months | −52.1% | +31.5% |
| Year to date | −47.0% | +12.0% |
| 1 year | −39.8% | −8.0% |
| Revenue growth (YoY) | +23.8% | +1775.4% |
| Gross margin | 95.2% | 89.9% |
| Net margin | −13.8% | −86.5% |
| P/E (TTM) | — | — |
| Price / sales | 1.8× | 9.0× |
| Net cash | $30.0M | $54.6M |
| Dividend yield | — | — |
| Volatility (60d) | 49.7% | 71.8% |
| Short % of float | 11.4% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).